Ethics & Informed Consent: Systematic Review & Meta-Analysis (Austria)

1. Ethical Principles & Legislative Framework

In research involving human participants, securing ethical clearance is a critical first step. For a Systematic Review & Meta-Analysis being conducted in Austria, study designs must align with the primary regulatory legislation: Medicines Act (Arzneimittelgesetz - AMG). This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.

Administrative review and formal approval are managed by a local or regional Ethikkommission (Ethics Commission). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.

2. Study Design Elements & Reporting Integrity

For a Systematic Review & Meta-Analysis, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.

Study Classification: Exempt (No Human Participant Recruitment)

This design synthesizes aggregate results from prior literature. Direct human ethics reviews are not required, but registering a clear search protocol is standard.

To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: PRISMA declaration.

3. Informed Consent & Information Sheet Guidelines

A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:

• Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
• Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
• Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under EU GDPR & Austrian Data Protection Act (Datenschutzgesetz - DSG).
• Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
• Ethics Board Contact Information: Provide the contact details of the reviewing Ethikkommission (Ethics Commission) so participants can reach out if they have questions or concerns.

Research Ethics, Clinical Trials & Institutional Governance

Evaluating source publications in this Systematic Review & Meta-Analysis in Austria relies on the Belmont Report principles of justice and academic honesty. The synthesis should screen primary works to ensure that no hidden deception in psychological research compromised patient safety. The secondary nature of this review means that individual research study consent form files are not gathered under informed consent Belmont Report rules. While we bypass standard clinical trial registration and a clinical trial agreement contract, registering the protocol on PROSPERO is recommended. The analysis does not use live animals, removing any need for the 3rs replacement reduction refinement protocols. All records and signed consent sheets must reside on secure local servers in Austria to protect patient privacy and comply with national guidelines.

4. Regulatory Checklist Table

To streamline your ethical review submission, use the structured alignment checklist below:

6. Frequently Asked Questions